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Abstract
Understanding the mechanisms through which multicellular organisms regulate cell, organ and body
growth is of relevance to developmental biology and to research on growth-related diseases such as
cancer. Here we describe a new effector in growth control, the small GTPase Rheb (Ras homologue
enriched in brain). Mutations in the Drosophila melanogaster Rheb gene were isolated as
growth-inhibitors, whereas overexpression of Rheb promoted cell growth. Our genetic and biochemical
analyses suggest that Rheb functions downstream of the tumour suppressors Tsc1 (tuberous sclerosis
1)-Tsc2 in the TOR (target of rapamycin) signalling pathway to control growth, and that a major
effector of Rheb function is ribosomal S6 kinase (S6K).
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Rheb is an essential regulator of S6K in controlling cell
growth in Drosophila
Hugo Stocker1, Thomas Radimerski2, Benno Schindelholz3, Franz Wittwer1, Priyanka Belawat1, Pierre Daram3,
Sebastian Breuer3, George Thomas2 and Ernst Hafen1
Understanding the mechanisms through which multicellular
organisms regulate cell, organ and body growth is of relevance
to developmental biology and to research on growth-related
diseases such as cancer. Here we describe a new effector in
growth control, the small GTPase Rheb (Ras homologue
enriched in brain). Mutations in the Drosophila melanogaster
Rheb gene were isolated as growth-inhibitors, whereas
overexpression of Rheb promoted cell growth. Our genetic and
biochemical analyses suggest that Rheb functions downstream
of the tumour suppressors Tsc1 (tuberous sclerosis 1)–Tsc2 in
the TOR (target of rapamycin) signalling pathway to control
growth, and that a major effector of Rheb function is ribosomal
S6 kinase (S6K).
A growing number of studies in genetically tractable model organisms,
such as D. melanogaster, have greatly enhanced our understanding of
growth regulation. From these efforts, two highly conserved signalling
pathways dedicated to the control of growth have emerged, namely the
insulin receptor (InR)/phosphatidylinositol-3-OH kinase (PI(3)K) and
TOR pathways1,2. Recent studies have also shown that these two path-
ways interact, although the mechanisms by which they communicate
are the subject of controversy3,4. In addition, each pathway seems to be
modulated by distinct tumour suppressor genes, PTEN (phosphatase
and tensin homologue deleted in chromosome 10) and TSC1–TSC2,
respectively5,6. Whereas it is clear that PTEN constrains PI(3)K sig-
nalling by dephosphorylation of phosphatidylinositol-3,4,5-triphos-
phate (PtdInsP3)
7, the mechanism by which TSC1 and TSC2
counteract TOR signalling remains elusive. Importantly, TSC2 pos-
sesses a putative GTPase-activating protein (GAP) domain, which has
been shown to increase the intrinsic GTPase activity of the small
GTPases Rap1 and Rab5 (refs 8, 9). Here, we present genetic and bio-
chemical data from Drosophila suggesting a novel role for the small
GTPase Rheb in the TOR/S6K signalling pathway.
To identify growth-regulating genes, we performed two comple-
mentary screens for loss- and gain-of-function mutations, respec-
tively. In the loss-of-function screen, we discovered a novel
complementation group of ten alleles that impair cell and organ
growth. The ethylmethane sulphonate (EMS)-induced mutations
were identified on the basis of reduced head size of mosaic animals,
consisting of heads largely made up of homozygous mutant cells and
bodies containing heterozygous cells (compare Fig. 1a with
Fig. 1b)10,11. This phenotype is reminiscent of mutations in InR sig-
nalling components. Genetic mapping of two representative alleles
and subsequent testing of candidate open reading frames identified
alterations in the gene CG1081 in seven alleles. CG1081 encodes a
small GTPase most closely related to mammalian Rheb12
(Supplementary Information, Fig. S1a). Therefore, we named this
complementation group Rheb.
The gain-of-function screen for genes that stimulate growth when
overexpressed resulted in the identification of an EP element in the
Rheb locus (EP 50.084). EP-mediated overexpression of Rheb in the
developing eye substantially increased eye size (Fig. 1c). We generated
six additional Rheb loss-of-function alleles by imprecise excision of EP
50.084. Whereas all combinations of the EMS-induced Rheb alleles
were lethal, some hetero-allelic combinations of EMS-induced alleles
and EP excision alleles were viable and resulted in flies of reduced size
(Supplementary Information, Fig. S1b). The size reduction was
caused by a decrease in cell number (3–11%), as well as in cell size
(9–14% in wing cells, more than 20% in eye cells as judged by omma-
tidial size). In addition, the small flies eclosed with a delay of at least
one day and the females had rudimentary ovaries and were sterile
(Fig. 1d). Thus, the surviving Rheb mutant flies display all the hall-
marks of impaired InR signalling activity, resembling flies lacking the
insulin-receptor substrate (IRS) protein Chico10.
A more severe reduction in Rheb function (in heteroallelic combi-
nations of Rheb mutations) was lethal at late larval or early pupal
stages. Mutant larvae and pupae were consistently smaller (Fig. 1e, f),
although the phenotype was variable. Interestingly, the size reduction
was more pronounced in the endoreplicative larval tissue than in the
imaginal discs (Fig. 1g–j), similarly to the larval phenotype of TOR
mutants13,14. Staining of DNA in salivary glands and fat body cells
demonstrated a severe deficit in endoreplication (Fig. 1j).
The behaviour of Rheb mutant cells was studied during develop-
ment by means of mitotic recombination. Clones of cells homozygous
for EMS-induced Rheb alleles grew poorly and were consistently
smaller than their corresponding sister clones (Fig. 2a). When pro-
vided with a proliferative advantage (by means of the Minute tech-
nique), Rheb mutant cells still failed to cover large regions of the
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imaginal discs. Instead, the resulting clones typically displayed elon-
gated shapes with thin extensions (Supplementary Information,
Fig. S2a). A possible explanation for this unusual phenotype may
reside in their attempt to minimise contact with other mutant cells. To
our knowledge, this phenomenon has not been previously described in
the context of growth-regulating genes. Despite this abnormal behav-
iour, Rheb mutant cells differentiate properly into adult structures. For
example, analysis of clones in the adult eye revealed the presence of
extremely small photoreceptor cells of otherwise normal structure and
arrangement in the mutant tissue (Fig. 2b). The size reduction pheno-
type is strictly cell-autonomous. Taken together, the characterisation
of the mutant phenotypes demonstrates that Rheb is required for
proper growth regulation in a cell-autonomous manner.
Next, we examined whether overexpression of Rheb is sufficient to
promote growth. The effect of overexpressing Rheb during develop-
ment through the use of the EP 50.084 line and two independent UAS-
Rheb lines was monitored in marked clones in imaginal discs and in
the adult eye. All the lines yielded qualitatively similar results, with the
EP line consistently showing the strongest effects. Clones overexpress-
ing Rheb in the wing imaginal disc attained a substantially larger size
when compared with control clones (Fig. 2c). This enlargement is
caused by a significant increase in cell size (a 48% increase in area cov-
ered per cell). In contrast, the cell doubling time remained unchanged
in cells expressing Rheb versus control cells (10.5 h versus 10.8 h).
Consistent with the size effect in the imaginal discs, cells expressing
Rheb in differentiating cells posterior to the morphogenetic furrow
(under the control of GMR regulatory sequences) resulted in enlarged
but fully differentiated photoreceptor cells (a 66% size increase of the
rhabdomeres; Fig. 2d). As in the case of the loss-of-function clones, the
size alteration was cell-autonomous. Thus, Rheb is sufficient to pro-
mote cellular growth.
As both InR and TOR signalling have been implicated in the
response to nutrient availability15,16, we asked whether overexpression
of Rheb would promote growth even under starvation conditions. It
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Figure 1 Growth defects caused by Rheb mutations. (a–c) Phenotypes that
resulted in the identification of Rheb alleles. Shown are SEMs of female fly
eyes taken at the same magnification. EMS-induced Rheb loss-of-function
alleles were identified on the basis of the pinhead phenotype in mosaic
animals with largely homozygous mutant heads, as shown in a. A
comparison with a control eye, as shown in b, demonstrates the marked size
reduction. An EP-element driving Rheb expression was isolated as a gain-of-
function mutation promoting overgrowth in the eye, as shown in c. (d)
Ovaries of viable Rheb7A1/Rheb44.1 females (bottom) are markedly reduced
in size when compared with control ovaries (top). (e, f) Phenotype of a pupal
lethal heteroallelic combination (Rheb7A1/Rheb26.2). The size range of
mutant larvae (e, middle and right) is shown in comparison with a control
larva (left). Whereas the smaller mutant larvae die, the larger mutant larvae
arrest development at the early pupal stage. A corresponding pupa (f, right)
is clearly smaller than the control pupa (left). (g–j) Size defects of imaginal
discs and salivary glands in larvae of a pupal lethal heteroallelic
combination (Rheb3M2/Rheb26.2). Whereas the size reduction of mutant
imaginal discs is roughly proportional to the larval size (g, control; h,
mutant), the salivary glands are more severely reduced (compare j to control
gland in i). DAPI staining (blue) shows a strong endoreplication deficit in
Rheb mutant salivary glands. Membranes are stained with an anti-lin7
antibody (red).
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Figure 2 Clonal analysis of Rheb function. (a) Loss-of-function clones in the
wing imaginal disc are consistently smaller than their corresponding twin
clones. A clone of cells homozygous mutant for Rheb2D1 (marked by the
absence of GFP) is only about half the size of its twin spot (bright green
staining). Nuclei are labelled by DAPI staining (shown in red). The reduced
clone size is accounted for by fewer and smaller cells (n = 10, P = 0.00038
for cell number, P = 0.00126 for cell size). (b) Tangential sections through
compound eyes reveal that cells homozygous mutant for Rheb3M2 (marked
by the lack of pigments) are able to differentiate into the various cell types
of the eye. The size of the mutant cells, however, is greatly reduced (as
reflected by a 72% reduction in rhabdomere area in tangential sections). A
mosaic ommatidium containing a single mutant photoreceptor cell (inset,
asterisk) demonstrates the cell-autonomy of the size reduction. (c) Flp-out
clones of Rheb-expressing cells in the wing imaginal disc attain a
significantly larger size. Clones 40 h after induction and marked by GFP
expression are shown (top: control, bottom: expressing Rheb). The increase
in clonal area is caused by larger cells (n = 20, P = 0.00002), whereas the
number of cells is not significantly altered (P = 0.087). (d) Expression of
Rheb during eye development results in an enlargement of photoreceptor
cells. Cells expressing Rheb under GMR-control are marked by the absence
of pigmentation. Cell-autonomy of the size increase is demonstrated by a
single Rheb-expressing photoreceptor cell (asterisk) in a mosaic
ommatidium (inset). (e–h) The effects of Rheb expression in endoreplicative
larval tissues under normal conditions (e, g) and under amino-acid
deprivation (f, h). Cells expressing Rheb (labelled with GFP, arrows in lower
panels) under normal nutrient availability in salivary glands (e) and fat body
cells (g) display only a mild size increase. In larvae starved for amino acids,
however, Rheb expression exerts strong effects on both cell size and DNA
ploidy. In salivary glands (f), Rheb-expressing cells display a several fold
increase in size and contain much more DNA (stained with DAPI, lower
panels) than non-expressing neighbouring cells, but they do not reach
normal size and ploidy. In the fat body cells (h), expression of Rheb reverts
the starvation phenotype completely. Size, DNA content, and appearance
(amount of vesicles) of these cells are indistinguishable from non-starved
cells. Membranes are visualised with an anti-lin7 antibody staining (red).
Separate DAPI staining is shown in lower panels (blue).
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has been shown that depriving larvae of amino acids blocks endorepli-
cation of the larval tissues, but that this can be overcome by expression
of Dp110/PI(3)K16. Rheb was expressed in small clones of cells in the
salivary glands and in the fat body. Under normal food conditions,
only a very subtle increase in cell size was observed (Fig. 2e, g). In lar-
vae starved of amino acids, however, Rheb expression had a pro-
nounced effect on both DNA content (as visualised by DAPI staining)
and cell size (Fig. 2f, h). Despite the lack of amino acids, larval cells
expressing Rheb reached a normal size in the fat body, and the size and
endoreplication deficits were significantly alleviated in the salivary
glands. We conclude that Rheb is sufficient to counteract the effects of
amino-acid deprivation and thus may function in amino-acid sensing.
Given the similarities between Rheb and mutants in the InR and
TOR signalling pathways, it is conceivable that Rheb represents a novel
component of one of these growth control pathways. To test this possi-
bility, a detailed epistasis analysis was performed. First, we tested
whether the negative regulators of InR and TOR signalling — PTEN
and Tsc1–Tsc2, respectively — could counteract the effects of Rheb
overexpression. All overexpression experiments were performed in the
eye using the GMR-Gal4 driver line. Expression of either PTEN or
Tsc1–Tsc2 alone resulted in a very similar size reduction of the omma-
tidia (Fig. 3b, c) when compared with control ommatidia (Fig. 3a)17–20.
However, whereas expression of PTEN had no influence on the
increase in ommatidial size caused by Rheb overexpression (Fig. 3g),
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Figure 3 Epistatic relationship of Rheb with the InR/dPI(3)K and the TOR
signalling pathways. (a–l) SEMs showing ommatidial size and shape of
female flies. (a) Control (b) GMR-Gal4/+; UAS-PTEN/+ (c) GMR-Gal4/+;
UAS-Tsc1 UAS-Tsc2/+ (d) PKB1/PKB3 (e) S6Kl-1/S6Kl-1 (f) GMR-Gal4/+;
EP50.084/+ (g) GMR-Gal4/+; EP50.084/UAS-PTEN (h) GMR-Gal4/+;
EP50.084/UAS-Tsc1 UAS-Tsc2 (i) GMR-Gal4/+; EP50.084 PKB1/PKB3 (j)
GMR-Gal4/+; S6Kl-1 EP50.084/S6Kl-1 (k) GMR-Gal4/TOR2L1;
EP50.084/+ (l) GMR-Gal4/TOR2L1; EP50.084/S6Kl-1. Ommatidial size
relative to the control is indicated in each panel. Expression of Rheb
under GMR-Gal4 control results in large and disorganised ommatidia (f).
This phenotype can be suppressed by co-expression of Tsc1–Tsc2 (h), but
not by PTEN (g). The enlarged ommatidial size is still evident in a PKB
mutant background (i), but is neutralised in flies lacking S6K function (j).
The effects of Rheb overexpression are dominantly alleviated by TOR2L1
(k). (m–r) SEMs showing heads of mosaic female flies generated by the ey-
Flp method. The heads are largely homozygous mutant for (m) Control (n)
PTEN2L117 (o) Tsc12G3 (p) Rheb2D1 (q) PTEN2L117 and Rheb2D1 (r)
Rheb2D1 and Tsc12G3. Note that Rheb is epistatic over both PTEN and
Tsc1, as indicated by the Rheb-like phenotype of the respective double
mutants as shown in q and r. (s) Pupae doubly mutant for Tsc1 and Rheb
(upper panel, right) are smaller than heterozygous control pupae (left).
Animals lacking Tsc1 do survive if Rheb function is compromised (lower
panel, bottom). The surviving flies are slightly reduced in size when
compared with the heterozygous control (top). Genotypes are: Tsc12X1,
Rheb2D1/TM3 (heterozygous control animals), Tsc12X1, Rheb2D1/Tsc11A2,
Rheb7A1 (doubly mutant animals).
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co-expression of Tsc1–Tsc2 resulted in ommatidia of approximately
wild-type size (Fig. 3h), indicating that the activities of Rheb and
Tsc1–Tsc2 can counteract each other. Next, the enlarged ommatidia
phenotype of GMR-Rheb was assayed in a number of mutant back-
grounds. Reducing the activity of Drosophila protein kinase B (PKB)
had no effect on the ommatidial size (Fig. 3i). Similar results were
obtained with hypomorphic mutations in InR and Dp110, respectively
(data not shown). In contrast, ommatidial size was dominantly
reduced by a mutation in TOR (TOR2L1; Fig. 3k), and a suppression to
wild-type size was observed in a S6K mutant background (Fig. 3j).
Thus, the Rheb overexpression phenotype is dependent on TOR and
S6K function, but is independent of InR signal strength. Finally, we
analysed the behaviour of Rheb PTEN and Rheb Tsc1 double mutants.
The phenotypic consequences were assayed in mosaic animals using
the ey-Flp method. As expected, the Rheb PTEN double-mutant tissue
clearly displayed a Rheb phenotype (Fig. 3q). The Rheb Tsc1 mutant
tissue also resembled Rheb single mutants (Fig. 3r), indicating that
Rheb is epistatic over Tsc1.
Complete loss of Tsc1 function results in larval lethality17,18,21.
Importantly, we found that a simultaneous reduction of Rheb function
was sufficient to restore viability. The emerging double-mutant flies
displayed a weak Rheb hypomorphic phenotype (a moderate size
reduction; Fig. 3s). These findings suggest that the major consequence
of a lack of Tsc1 is overactivation of Rheb.
Our genetic analysis indicated that Rheb regulates S6K through
TOR. Therefore, we tested whether S6K activity is dependent on Rheb
function. Larval extracts of various heteroallelic Rheb combinations
were subjected to S6K and PKB kinase assays. Indeed, S6K activity was
significantly reduced in all combinations without any apparent effect
on S6K protein levels (Fig. 4a). PKB activity, however, was consistently
increased (Fig. 4b). This is in agreement with the hypothesis that S6K
is an essential component of a negative feedback loop regulating InR
signalling22,23. Conversely, ubiquitous expression of Rheb resulted in
an increase in S6K activity (Fig. 4c) and a concomitant decrease in
PKB activity (Fig. 4d). The stimulation of S6K activity by Rheb was
also observed after amino-acid deprivation (Fig. 4e). Thus, Rheb is
both necessary and sufficient for S6K activation.
Although Rheb is essential for S6K activity, and the overgrowth phe-
notype elicited by Rheb overexpression depends on S6K, regulation of
S6K is clearly not the only effect of Rheb activity. Whereas flies lacking
S6K function are semi-viable (exhibiting a severe delay in development
and a reduced body size24), loss of Rheb is lethal. Moreover, reduction
of Rheb activity results in a decrease in cell number and cell size (as
opposed to S6K mutants, which only affect cell size). Finally, the char-
acteristic shape of Rheb mutant cell clones suggests that Rheb has other
functions in addition to growth control.
Two models of Rheb activity can be envisaged: first, Rheb could
function in the TOR signalling pathway directly downstream of and
negatively regulated by Tsc1–Tsc2 (Supplementary Information,
Fig. S3a). Second, Rheb might be a component of an independent
pathway that impinges on S6K (Supplementary Information,
Fig. S3b). In the latter model, the TOR signalling pathway and the
putative parallel pathway would both be necessary for the full activa-
tion of S6K. This could explain why impairing the activity of one path-
way interferes with the consequences of overactivating the other.
Nevertheless, we favour the former model because Rheb mutants show
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Figure 4 Rheb affects the kinase activities of S6K and PKB. (a) S6K
activity depends on Rheb function. Larval extracts of various Rheb
heteroallelic combinations were assayed for S6K kinase activity. All
combinations showed a significant reduction in the kinase activity. (b) In
contrast to the effect on S6K, reduction of Rheb function resulted in an
increase in PKB activity. (c) Ubiquitous expression of Rheb resulted in a
marked increase in S6K activity, accompanied by a decrease in PKB
activity (d). Kinase assays were performed 7 h after heat-shock-mediated
Rheb induction. (e) Amino-acid deprivation for 6 h (after 4 h recovery
from heat-shock) did not compromise the ability of Rheb to stimulate S6K
activity. Western blots of S6K and α-tubulin are shown as loading controls
in the bottom panels of a, c and e. 32P-CT: 32P-Crosstide. Western blots of
PKB and α-tubulin are shown as loading controls in the bottom panels of b
and d.
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striking similarities with TOR signalling defects and because of the
intimate genetic interactions of Rheb with Tsc1–Tsc2. A particularly
attractive hypothesis implicates Tsc2 as the GAP of Rheb. Indeed, in an
accompanying paper, Zhang et al. provide evidence that Tsc2 is the
GAP for Rheb in Drosophila (this issue), and the same conclusion has
been derived from studies on the mammalian homologues of
Drosophila Tsc2 and Rheb (F.J.T. Zwartkruis, J.L. Bos and G.T., per-
sonal communication).
Interestingly, loss of rhb1 function in the fission yeast
Schizosaccharomyces pombe results in a growth arrest phenotype that is
very similar to that of nitrogen-starved cells25. Thus, the function of
Rheb in growth regulation in response to nutrients (amino acids) may
have been conserved during evolution. Furthermore, the fact that
impaired Rheb function is sufficient to suppress the phenotypic conse-
quences of loss of PTEN and TSC1–TSC2 suggests that Rheb might be
a suitable target for therapeutic intervention in a wide range of
tumours.
METHODS
Genetics. EMS-induced Rheb alleles were isolated in an ey-Flp mosaic screen26
that will be described elsewhere. Two alleles, Rheb2D1 and Rheb2G5, were
mapped genetically with respect to visible markers. A subsequent fine mapping
step placed the mutations between the P-element insertions EP974 (83A3) and
l(3)j1C2 (83C1-2) in a candidate region of 312.5 kb. Eight polymorphisms dis-
tributed over the candidate region were used to establish a high-resolution SNP
map. The candidate region could be narrowed down to 60 kb by mapping the
recombination sites between the Rheb alleles and the two P elements using SNP
detection by DHPLC27. Candidate open reading frames in this interval were
amplified by PCR from heterozygous Rheb flies and tested for polymorphisms
by DHPLC. Amplified fragments of CG1081 displayed various polymorphisms
and were subsequently sequenced.
The EP line 50.084 was identified among 10,000 novel insertions of a double-
headed EP element. It is inserted six nucleotides downstream of the 5′ end of
the first exon of transcript CG1081-RA (GadFly database). The EP50.084 chro-
mosome carries a closely linked lethal factor that cannot be reverted by mobili-
sation of the EP element. The UAS sites at the 5′ end of EP50.084 were excised
by Cre-loxP-mediated recombination to yield a single-headed EP element capa-
ble of driving Rheb. EP50.084 was remobilised by crossing in the transposase
source ∆2-3 to generate imprecise excision alleles. At least 83 independent
reversions of the dominant yellow+ marker were recovered; six of them failed to
complement the Rheb alleles. The two imprecise excision alleles that yielded
viable combinations with some EMS-alleles (Rheb44.1 and Rheb56) retained par-
tial sequences of the EP element (0.6 and 1.1 kb, respectively) without deleting
any flanking genomic sequences.
The following transgenes and mutations were used for interaction studies:
GMR-Gal4 (ref. 28), UAS-PTEN (ref. 20), UAS-Tsc1, UAS-Tsc2 (ref. 17),
PKB1 (ref. 29), PKB3 (ref. 30), TOR2L1 (ref. 13), S6Kl-1 (ref. 24), PTEN2L117 (ref.
31), Tsc12G3, Tsc12X1 and Tsc11A2 (H.S. and E.H., unpublished observations).
To generate loss-of-function clones, we used the lines y w hs-Flp; FRT82 Ubi-
GFP and y w hs-Flp; FRT82 Ubi-GFP M / TM6B for clones in the imaginal discs,
and y w hs-Flp; FRT82 w+ M / TM6B for clones in the adult eye. Clones were
induced in 48–72-h-old larvae by a 45-min heat-shock at 34 °C. To circumvent
potential side effects caused by second hits, at least three different EMS-induced
Rheb alleles were tested in each experiment. The results were always qualita-
tively similar.
Overexpression clones were generated by means of the ‘FLP-out’ technique
using the lines y w hs-Flp; Act>CD2>Gal4 UAS-GFPnls / TM6B (ref. 32) and y w
hs-Flp; GMR>w+>Gal4 (ref. 33), respectively. FLP-out clones were induced
either in 80-h-old larvae by a 13-min heat-shock at 34 °C (Act>CD2>Gal4), or
in 24–48-h-old larvae by a 1-h heat-shock at 37 °C (GMR>w+>Gal4). To
achieve overexpression in the endoreplicative larval tissues, spontaneous FLP-
out events using y w hs-Flp; Act>CD2>Gal4 UAS-GFPnls / TM6B without heat-
shock application were recovered16. All the overexpression experiments were
performed using EP50.084 and two UAS-Rheb lines (individually or in combi-
nation). The severity of the resulting phenotypes was always in accordance with
the order EP50.084 > UAS-Rheb13.1+14.2 > UAS-Rheb14.2 > UAS-Rheb13.1,
presumably reflecting different expression levels. To deprive larvae of dietary
amino acids, 60-h-old larvae were incubated in 20% sucrose solution.
Eye-specific clones were generated using the ey-Flp system, as previsouly
described26. For the double-mutant analysis of PTEN Rheb clones, the ey-Flp
systems for 2L and 3R were combined to induce clones simultaneously for
FRT40 PTEN2L117 and FRT82 Rheb. To study the effects of Rheb Tsc1 double
mutants, recombinant chromosomes were generated with various alleles.
Gal4 under control of a heat-shock promoter (hs-Gal4) was used to ubiqui-
tously overexpress Rheb. Second-instar larvae were transferred to tubes con-
taining fresh squashed fly food and placed in a waterbath at 37 °C for 45 min.
Then larvae were allowed to recover at room temperature for the indicated
times before analysis in kinase assays.
Measurements and data analysis. The body weight of male flies three days after
eclosion was measured with a precision scale (Mettler Toledo, Greifensee,
Switzerland). Wings of female flies were mounted and analysed as previously
described10. Scanning electron microscope (SEM) images of five female fly eyes
per genotype were analysed to characterise the eye phenotypes. Rosettes of
seven ommatidia were measured using the NIH image software to determine
ommatidial area.
Extraction of larvae, kinase assays and western blotting. Larvae were extracted
essentially as described13, however with a modified extraction buffer (120 mM
sodium chloride, 50 mM Tris-HCl at pH 7.0, 20 mM sodium fluoride, 1 mM
benzamidine, 1 mM EDTA, 6 mM EGTA, 15 mM Na4P2O7-10H2O and 1% NP-
40; the following reagents were added shortly before use to the indicated con-
centrations: 1/5 volume Complete Mini protease inhibitor cocktail (Roche
Diagnostics, Rotkreuz, Switzerland) prepared as a 5× stock in extraction buffer
without the reagents listed hereafter, 2 mM AEBSF (Pefabloc SC (Roche)), 30
mM para-nitrophenylphosphate, 30 mM β-glycerolphosphate, 4 µM leu-
peptin, 2 µM aprotinin, 4 µM pepstatin and 100 µM phenyl methylsulphonyl
fluoride).
Kinase activity assays of either S6K or PKB were performed as described13,22.
For immunoblotting, the following antibodies were used at the indicated
dilutions: S6K D-20 antibody at 1:200 (ref. 24), PKB antibody (ref. 34) at
1:1000 and α-tubulin antibody (Sigma, St Louis, MO) at 1:1000. HRP-conju-
gated secondary antibodies (Dako A/S, Glostrup, Denmark) were diluted
1:2000. Signals were detected using ECL western blotting detection reagents
(Amersham Biosciences, Little Chalfont, Buckinghamshire, UK).
Note: Supplementary Information is available on the Nature Cell Biology website.
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Figure S1  Mutations in the highly conserved dRheb protein result in growth
impairment. a, At the amino acid level, dRheb shares 63% identity and 81% simi-
larity with human Rheb, and 51% identity and 72% similarity with S. pombe rhb1p,
respectively. The effector domain (amino acids 34-42 in dRheb) is identical in
human and Drosophila Rheb. The carboxy-terminal part is less well conserved. All
proteins contain a farnesylation sequence at the very carboxy-terminus. The alter-
ations resulting from the EMS-induced dRheb mutations are: dRheb3M2: translation
initiation codon mutated to ACG, dRheb5O1: I68M, dRheb7A1: V71K, dRheb4L1:
K101Stop, dRheb2D1: two nucleotide exchanges in the 5’ UTR, dRheb2G5: a combina-
tion of a deletion of eleven nucleotides and an insertion of six nucleotides in the
second intron, generating a putative novel splice acceptor site, dRheb1T1: splice site
mutation predicted to result in a protein consisting of the amino-terminal 16 amino
acids followed by DEFSQKVPPEALTLLLLALVIA. b, Quantification of the size defects
observed in heteroallelic combinations of dRheb alleles. The observed size reduc-
tion is due to fewer and smaller cells in the eyes and in the wings. All the reduc-
tions, with the exception of the reduced wing cell number in the genotype
dRheb2G5/dRheb44.1 (p=0.16), are statistically significant (p≤0.01).
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Figure S2  Unusual behaviour of cells lacking or overexpressing dRheb. a,
Even when provided with a growth advantage (by means of the Minute technique),
dRheb mutant cells fail to generate large clones. Instead, these clones are charac-
terised by extended thin branches (a’). Smaller clones that were induced later
already display an elongated shape (a). b, Clones of dRheb expressing cells have a
higher tendency to fuse. The single clone on the left touches a larger group of cells
probably consisting of two fused clones. Occasionally, fusions of multiple clones
can be observed (b’).
© 2003 Nature Publishing Group
supplementary infomation
3
dPKB
dPTEN
dS6K
dTOR
dRheb
dTsc1/2
dInr
dPI3K
Chico
dPKB
dS6K
dTOR
dTsc1/2
dPDK1
dInr
dPI3K
Chico
a b
dRheb
dPTEN
dPDK1
Figure S3 Alternative positions of dRheb in the growth regulatory network.
Schematic representation of the dInr/dPI3K and dTOR signalling pathways. The
activity of dS6K is under the control of dPDK1 33 and dTOR 13,14. Two links between
the dInr/dPI3K and the dTOR pathways have recently been described. dPKB can
negatively regulate dTsc1/2 function by phosphorylating dTsc2 35, and dS6K nega-
tively regulates dPKB activity (although the target of this negative feedback remains
unknown) 22. In our favoured model, dRheb is negatively regulated by the dTsc1/2
complex (possibly by the GAP activity of dTsc2) and positively acts on dTOR func-
tion (a). Alternatively, dRheb may function in a pathway parallel to dTsc1/2-dTOR
whose activity is essential for full activation of dS6K (b). The more severe (complex)
phenotypes caused by mutations in dPKB, dTOR, or dRheb as compared to muta-
tions in dS6K suggest that these proteins have additional as yet unknown growth
relevant targets (block arrows).
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